Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Trastuzumab and ECG Changes Di...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Trastuzumab and ECG Changes Dilemma

Trastuzumab and ECG Changes Dilemma

Trastuzumab and ECG changes dilemma

Bibliographic Details
Main Authors: Azin Alizadehasl, Mina Mohseni, Feridoun Noohi Bezanjani, Majid Maleki, Kamran Roudini
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2023-04-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
ECG Changes; Trastuzumab; Herceptin; Cardiotoxicity
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1738
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1738

Similar Items

  • The acute effect of trastuzumab infusion on ECG parameters in metastatic breast cancer patients
    by: M Yazici, et al.
    Published: (2007-10-01)
  • Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction
    by: Azin Alizadehasl, et al.
    Published: (2024-03-01)
  • Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
    by: Melissa Y. Y. Moey, et al.
    Published: (2019-07-01)
  • Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind Study
    by: Christian Schwabe, et al.
    Published: (2024-07-01)
  • Trastuzumab and cardiotoxicity
    by: Petra Sertić, et al.
    Published: (2024-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs